The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.90
Bid: 4.80
Ask: 5.00
Change: 0.05 (1.03%)
Spread: 0.20 (4.167%)
Open: 4.85
High: 4.90
Low: 4.85
Prev. Close: 4.85
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Data Access Licence and Royalty Agreement

13 Jan 2014 07:00

RNS Number : 4441X
Eden Research plc
13 January 2014
 



 

Eden Research Plc

("Eden" or "Company")

 

Data Access Licence and Royalty Agreement

 

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has granted access to its EU regulatory data and dossiers to Desarrollo Agricola y Minero S.A. ("Daymsa") of Zaragoza, Spain.

 

In 2013, Eden received approval for three active substances under the European Union Regulation ("EC") No. 1107/2009 concerning the Placing of Plant Protection Products on the Market. This data, which was generated by Eden to register its own plant protection product 3AEY, is also of value to third parties as a basis to register their own products using one or more of the same active substances.

 

Daymsa already uses similar natural ingredients in its existing product portfolio and shall now register new products using the data for the active substances registered by Eden.

 

Clive Newitt, Managing Director of Eden comments: "Having invested a considerable amount of time, money and effort into the EU approvals of the three active substances, it is pleasing to see a return on our investment through upfront and milestone payments, as well as royalties on commercial sales. Daymsa is a well-established business with presence in Europe and Latin America and so the potential reach of these new products is significant."

 

Juan Pardos, General Manager of Daymsa comments: "Daymsa, a leading producer in Europe of Leonardite, is a 34 year old Spanish company that specialized in "Bio-stimulant and Bio-control products" even before those terms became of general use in ecological and conventional agriculture. This strategic agreement with Eden will enable us to become a leading company in Europe not only as leading producer of Leonardite but also a leading producer of "Vegetable Extract based" Bio-Control products."

 

Enquiries:

 

Eden Research plc

www.edenresearch.com

Clive Newitt, Managing Director

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited

Tel: 0117 945 3471

John Wakefield

Walbrook PR Ltd

Tel: 020 7933 8780 or eden@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07980 541 893

Paul Cornelius (Investor Relations)

Mob: 07827 879 496

 

 

 

 

Notes:

 

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

 

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

 

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

 

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

 

The Company has a number of patents and has a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, identifying suitable industrial partners and entering into licence agreements.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

For more information about Eden, please visit www.edenresearch.com

  

 

 

 

 

Daymsa, Europe´s leading producer of Leonardite started producing Leonardite based soil amendment products as early as in 1979. Since that time our investment in Quality and Sustainable Agriculture has been strengthened with the development of a full range of Bio-stimulant and Bio-control Products.

 

The increase in the world's population, a higher percentage of the world population entering the consumer market and the harsh competition of the Bio-Fuels over the limited land resources compelled Bio-technological companies like Daymsa to force their Research and Development departments into the search for solutions that can help to increase the world production of food, maintaining and increasing the long term quality and richness of the land.

 

The Sustainable Agriculture Solutions of Daymsa include a full range of

a) Soil and water conditioners

b) Bio-stimulants

c) Bio-control Products

d) Specialized microelement deficiency amendments

 

The actual Biocontrol portfolio products of Daymsa is based on the broad experience of Daymsa and its three subsidiary companies established in Brazil, Colombia and Ecuador not only in the European and Southern American market but also in the Middle East and North American countries. The Strategical Agreement signed with Eden will allow Daymsa to become one of the first producer of very effective Plant Protection Products based on Plant Extracts Registered in Europe.

 

For more information about Daymsa, please visit www.daymsa.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRGGUPCGUPCGQP
Date   Source Headline
24th Jun 202012:20 pmRNSResult of AGM
29th May 20207:58 amRNSIssuing of Annual Report & Notice of AGM
27th May 20207:00 amRNSUpdate on Bayer Animal Health Agreement
20th May 20207:00 amRNSNew authorisations for Cedroz and Mevalone
7th May 20207:00 amRNSFinancial Results for Year Ended 31 December 2019
6th May 20205:09 pmRNSNotice of Results
15th Apr 20207:00 amRNSAppointment of Director of Regulatory Affairs
8th Apr 202010:03 amRNSOrganic farming certification in Italy and Spain
24th Mar 20208:20 amRNSHolding(s) in Company
20th Mar 20205:33 pmRNSHolding(s) in Company
20th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 202010:33 amRNSHolding(s) in Company
18th Mar 202011:18 amRNSResults of General Meeting & Open Offer
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 20201:35 pmRNSPlacing, Subscription & Open Offer
20th Jan 20207:00 amRNSAppointment of Hawthorn Advisors
14th Jan 20207:00 amRNSYear-end trading update
8th Jan 20207:00 amRNSAgreement with Corteva Agriscience
7th Jan 20207:00 amRNSRegulatory Approval- Organic Production Regulation
23rd Dec 20197:00 amRNSAgreement with Sipcam Oxon in Portugal and Benelux
19th Dec 20197:00 amRNSApproval of Cedroz in Mexico
17th Dec 20197:00 amRNSDistribution Agreement with SumiAgro Europe
16th Oct 201912:48 pmRNSDirector/PDMR Shareholding
16th Oct 20197:00 amRNSCedroz Approval
18th Sep 20197:00 amRNSHalf Yearly Report
29th Jul 20197:00 amRNSGrant of 'Emergency use' authorisation
8th Jul 20197:00 amRNSChange of Adviser
28th Jun 20192:42 pmRNSReplacement - Grant of Awards
28th Jun 201911:43 amRNSGrant of Awards under Long-Term Incentive Plan
28th Jun 20197:00 amRNSDirector/PDMR Shareholding
12th Jun 20197:00 amRNSAppointment of Commercial Director
15th May 20198:10 amRNSResult of AGM
14th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSSales of Cedroz commence in Italy
26th Apr 20197:00 amRNSItaly grants "emergency use" Cedroz authorisation
16th Apr 201912:43 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSIssuing of Annual Report & Notice of AGM
2nd Apr 20197:00 amRNSFinancial Results for Year Ended 31 December 2018
5th Mar 20192:05 pmRNSSecond Price Monitoring Extn
5th Mar 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSEU Product Authorisation - Cedroz
15th Jan 20197:00 amRNSYear-end trading update
20th Dec 20187:00 amRNSSipcam exercises Option for distribution
5th Dec 20188:00 amRNSHolding(s) in Company
5th Dec 20188:00 amRNSHolding(s) in Company
30th Nov 20188:30 amRNSHolding(s) in Company
13th Nov 20187:00 amRNSEastman highly commended at Agrow Awards
15th Oct 20187:00 amRNSSipcam agreement for Australia and New Zealand
10th Oct 20189:00 amRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSApproval of TerpeneTech head-lice product

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.